Trial Profile
Antipsychotic Effects of Oxytocin
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 30 Sep 2021
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Travere Therapeutics
- 15 Nov 2019 Status changed from suspended to discontinued.
- 11 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
- 11 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2018.